Effect of Bifidobacterium Breve B-3 on Body Fat in Obese Adults

Exclusion Criteria

• •Within the last 6 months, severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), heart disease(Angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment), or malignant diseases (however, although subjects have a history of cerebrovascular disease and heart disease, they can be included if their status are clinically stable)
• •Patients with uncontrolled hypertension (blood pressure greater than 160/100 mmHg)
• •Diabetic patients with poor glycemic control with a fasting blood glucose of 160 mg/dl or more
• •Those who are treated with hypothyroidism or hyperthyroidism
• •Creatinine levels: more than twice the normal upper limit
• •Aspartate transaminase (AST), Alanine transaminase (ALT) levels: more than twice the normal upper limit
• •Those complaining of severe gastrointestinal symptoms such as heartburn and indigestion
• •Drugs that affect weight within the last month (absorption inhibitors and Appetite suppressant, health food / supplements related to obesity improvement, psychiatric Drugs, beta blockers, diuretics, birth control pills, steroids, female hormones) If you are taking
• •Participated in the commercial obesity program within the last 3 months.
• •If you have participated or are planning to participate in another clinical trial within the past month If yes
• •Alcohol abuser
• •Smoking abstinence within 3 months
• •If they are pregnant or lactating or have a pregnancy plan during the clinical trial
• •Those with allergic reactions to the constituent food
• •Any person deemed inappropriate by the researcher for other reasons